Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz et al. · Clinical Infectious Diseases · 2011 · 3.4K citations

Pharmacy, Infectious Diseases, Oncology +17

The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

Jean Klášterský, Marianne Paesmans, Edward Rubenstein et al. · Journal of Clinical Oncology · 2000 · 1.2K citations

Medicine, Health Sciences, Oncology +15

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

Philip A. Pizzo, K.J. Robichaud, Fred A. Gill et al. · The American Journal of Medicine · 1982 · 869 citations

Pharmacy, Oncology, Pharmacology +16

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia

Diana Averbuch, Christina Orasch, Catherine Cordonnier et al. · Haematologica · 2013 · 635 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

Manuela Aguilar‐Guisado, Ildefonso Espigado, Almudena Martín‐Peña et al. · The Lancet Haematology · 2017 · 241 citations

Pharmacy, Clinical Sciences, Oncology +15